World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Biology and Biochemistry
USA
2026

D-Index & Metrics

Best Scientists

D-Index
222
Citations
200521
World Ranking
127
National Ranking
89

Biology and Biochemistry

D-Index
218
Citations
192405
World Ranking
22
National Ranking
19

Medicine

D-Index
227
Citations
207200
World Ranking
71
National Ranking
54

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in United States Leader Award
  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Biology and Biochemistry in United States Leader Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Biology and Biochemistry in United States Leader Award
  • 2016 - Fellow of the American Academy of Arts and Sciences
  • 2016 - Fellow, National Academy of Inventors
  • 2015 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Radiology
  • 2009 - Member of the National Academy of Medicine (NAM)
  • 2004 - J. Allyn Taylor International Prize in Medicine, Robarts Research Institute

Overview

Ralph Weissleder is affiliated with Harvard University in the United States. Their research focuses primarily on biochemistry, genetics, and molecular biology, with extensive work also in medicine. Their subfields of study include molecular biology, immunology, oncology, biomedical engineering, and cancer research.

The main topics in Weissleder's work cover a range of advanced biomedical and cancer-related research areas. These topics include extracellular vesicles in disease, immune cells in cancer, advanced biosensing and bioanalysis techniques, single-cell and spatial transcriptomics, immunotherapy and immune responses, nanoplatforms for cancer theranostics, and microRNA in disease regulation.

Weissleder has published numerous papers, several of which are highly cited. Recent publications include:

  • CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers, 2023, Science
  • COVID-19 diagnostics in context, 2020, Science Translational Medicine
  • A neutrophil response linked to tumor control in immunotherapy, 2023, Cell
  • Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease, 2021, Nature
  • Radiotheranostics: a roadmap for future development, 2020, The Lancet Oncology

Frequent co-authors in Weissleder's research include Rainer H. Köhler, Hakho Lee, Miles A. Miller, Mikaël J. Pittet, and Jonathan Carlson. These collaborations have supported Weissleder's contributions across various biomedical and translational science fields.

Weissleder's work has been regularly published in venues such as bioRxiv (Cold Spring Harbor Laboratory), Advanced Science, Advanced Biosystems, ACS Nano, and Bioconjugate Chemistry.

The scientist has received several awards, recognizing their contributions to biomedical research. These honors include:

  • Fellow, National Academy of Inventors (2016)
  • Fellow of the American Academy of Arts and Sciences (2016)
  • Member of the German National Academy of Sciences Leopoldina for Radiology (2015)
  • Member of the National Academy of Medicine (2009)
  • J. Allyn Taylor International Prize in Medicine, Robarts Research Institute (2004)

Best Publications

  • A clearer vision for in vivo imaging.

    Ralph Weissleder

  • Imaging in the era of molecular oncology

    Ralph Weissleder;Mikael J. Pittet

  • The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

    Matthias Nahrendorf;Filip K. Swirski;Elena Aikawa;Lars Stangenberg

  • Identification of splenic reservoir monocytes and their deployment to inflammatory sites

    Filip K. Swirski;Matthias Nahrendorf;Martin Etzrodt;Martin Etzrodt;Moritz Wildgruber

  • Epigenetic memory in induced pluripotent stem cells

    K. Kim;A. Doi;B. Wen;K. Ng

  • Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

    Mukesh G. Harisinghani;Jelle Barentsz;Peter F. Hahn;Willem M. Deserno

  • Shedding light onto live molecular targets

    Ralph Weissleder;Vasilis Ntziachristos

  • Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

    Maïté Lewin;Nadia Carlesso;Ching Hsuan Tung;Xiao Wu Tang

  • Restoration of p53 function leads to tumour regression in vivo

    Andrea Ventura;David G. Kirsch;David G. Kirsch;Margaret E. McLaughlin;David A. Tuveson

  • In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.

    Ralph Weissleder;Ching-Hsuan Tung;Umar Mahmood;Alexei Bogdanov

  • Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

    Haoqiang Ying;Alec C. Kimmelman;Costas A. Lyssiotis;Sujun Hua

  • Looking and listening to light: the evolution of whole-body photonic imaging.

    Vasilis Ntziachristos;Jorge Ripoll;Jorge Ripoll;Lihong V Wang;Ralph Weissleder

  • New Technologies for Analysis of Extracellular Vesicles

    Huilin Shao;Hyungsoon Im;Cesar M. Castro;Xandra Breakefield

  • Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

    Jeffrey A. Engelman;Jeffrey A. Engelman;Liang Chen;Xiaohong Tan;Katherine Crosby

  • Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

    Filip K. Swirski;Peter Libby;Elena Aikawa;Pilar Alcaide

  • Superparamagnetic iron oxide: Pharmacokinetics and toxicity

    R. Weissleder;D. D. Stark;B. L. Engelstad;B. R. Bacon

  • Near-infrared fluorescence: application to in vivo molecular imaging

    Scott A Hilderbrand;Ralph Weissleder

  • Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.

    R Weissleder;G Elizondo;J Wittenberg;C A Rabito

  • Molecular Imaging in Cancer

    Ralph Weissleder

  • Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

    Vasilis Ntziachristos;Christoph Bremer;Ralph Weissleder

Frequent Co-Authors

Matthias Nahrendorf
Matthias Nahrendorf Harvard University
Lee Josephson
Lee Josephson Harvard University
Filip K. Swirski
Filip K. Swirski Icahn School of Medicine at Mount Sinai
Alexei A. Bogdanov
Alexei A. Bogdanov University of Massachusetts Chan Medical School
Ching-Hsuan Tung
Ching-Hsuan Tung Cornell University
Mikael J. Pittet
Mikael J. Pittet University of Geneva
Peter Libby
Peter Libby Brigham and Women's Hospital
Elena Aikawa
Elena Aikawa Brigham and Women's Hospital
Vasilis Ntziachristos
Vasilis Ntziachristos Technical University of Munich
Thomas J. Brady
Thomas J. Brady Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Ralph Weissleder

Trending Scientists

Recently Published Articles